Ocular adverse events associated with antibody-drug conjugates: a comprehensive pharmacovigilance analysis
IntroductionAntibody-drug conjugates (ADCs) are increasingly utilized in patients with solid tumors and hematologic malignancies. However, the adverse ocular toxicity induced by ADCs has not been comprehensively evaluated in real-world clinical settings.MethodsData from April 2019 to March 2024 base...
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2024-12-01
|
| Col·lecció: | Frontiers in Immunology |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1495137/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|